Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

XBI Guru Trades in

XBI Guru Trades in

Q1 2016

XBI Guru Trades in Q1 2016

First Eagle Investment 18,150 sh (New)
» More
Q2 2016

XBI Guru Trades in Q2 2016

Steven Cohen 191,000 sh (New)
First Eagle Investment 18,150 sh (unchged)
» More

Ratios

vs
industry
vs
history
P/B 5.21
XBI's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 5.21 )
Ranked among companies with meaningful P/B only.
XBI' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 5.21
Current: 5.21
0
5.21

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.49
XBI's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.49 )
Ranked among companies with meaningful Dividend Yield only.
XBI' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.49
Current: 0.49
0
0.49
Yield on cost (5-Year) 0.49
XBI's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.49 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
XBI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.49
Current: 0.49
0
0.49

More Statistics

Short Percentage of Float0.00%
52-Week Range $45.73 - 218.67
Shares Outstanding (Mil)34,850,000.00
» More Articles for XBI

Headlines

Articles On GuruFocus.com
VR Is not a Toy, it Is a Tool Aug 29 2016 
August Buffett-Munger Bargain Newsletter is Ready for Download Aug 29 2016 
What the iPhone 7 Does Not Mean for Apple Aug 29 2016 
Ford Europe Success Masked by Trouble on US Shores Aug 29 2016 
Innovation, Not Sales Growth, Is Procter & Gamble’s Challenge Aug 29 2016 
Choose How Many Stocks You Will Own Aug 29 2016 
Will the Checkbook Survive Online Payments? Aug 29 2016 
Why Under Armour Can Still Move Higher Aug 29 2016 
GNC is a Joel Greenblatt Bargain Walking a Tight Rope Aug 29 2016 
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Aug 29 2016 

More From Other Websites
Biotech Stocks: Look Who's Selling Aug 29 2016
Biotech ETFs in Focus After Mylan's EpiPen Controversy Aug 26 2016
Could Zinbryta Become a Novel Immunomodulatory Therapy for MS? Aug 26 2016
How Advisors Evaluate Industry, Sector ETFs Aug 24 2016
Medivation: The Latest Analyst Recommendations Aug 24 2016
It Could Be An Interesting Ride For Healthcare ETFs Aug 23 2016
Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts Aug 22 2016
Healthcare Investors May Be Pricing In A Clinton Victory Aug 17 2016
Charting the U.S. benchmarks’ pulling-teeth breakout attempt Aug 16 2016
Tuesday links: operating in silos Aug 16 2016
US Consumer Sentiment Is Below the Forecast Aug 16 2016
Bulls are chasing uptrend in biotech fund Aug 15 2016
Biotech Stocks: The Rebirth of the Bull? Aug 15 2016
Active Traders Turn Bullish on Biotech Aug 11 2016
Crushed Bio-Tech leader falls 90%, now attempting breakout Aug 09 2016
The Week Ahead: Is Macro Really Wacko? Aug 06 2016
Why Markets Remained Range Bound after US Data Release Aug 05 2016
Biogen surges on takeover talk. 4 Trades Aug 02 2016
2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You? Aug 02 2016
Is BioMarin Set to Become Profitable in 2017? Aug 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK